26420861|t|Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts.
26420861|a|Insulin resistance (IR) is a precursor of type 2 diabetes (T2D), and improved risk prediction and understanding of the pathogenesis are needed. We used a novel high-throughput 92-protein assay to identify circulating biomarkers for HOMA of IR in two cohorts of community residents without diabetes (n = 1,367) (mean age 73 +- 3.6 years). Adjusted linear regression identified cathepsin D and confirmed six proteins (leptin, renin, interleukin-1 receptor antagonist [IL-1ra], hepatocyte growth factor, fatty acid-binding protein 4, and tissue plasminogen activator [t-PA]) as IR biomarkers. Mendelian randomization analysis indicated a positive causal effect of IR on t-PA concentrations. Two biomarkers, IL-1ra (hazard ratio [HR] 1.28, 95% CI 1.03-1.59) and t-PA (HR 1.30, 1.02-1.65) were associated with incident T2D, and t-PA predicted 5-year transition to hyperglycemia (odds ratio 1.30, 95% CI 1.02-1.65). Additional adjustment for fasting glucose rendered both coefficients insignificant and revealed an association between renin and T2D (HR 0.79, 0.62-0.99). LASSO regression suggested a risk model including IL-1ra, t-PA, and the Framingham Offspring Study T2D score, but prediction improvement was nonsignificant (difference in C-index 0.02, 95% CI -0.08 to 0.12) over the T2D score only. In conclusion, proteomic blood profiling indicated cathepsin D as a new IR biomarker and suggested a causal effect of IR on t-PA.
26420861	23	41	Insulin Resistance	Disease	MESH:D007333
26420861	46	61	Type 2 Diabetes	Disease	MESH:D003924
26420861	99	117	Insulin resistance	Disease	MESH:D007333
26420861	119	121	IR	Disease	MESH:D007333
26420861	141	156	type 2 diabetes	Disease	MESH:D003924
26420861	158	161	T2D	Disease	MESH:D003924
26420861	339	341	IR	Disease	MESH:D007333
26420861	388	396	diabetes	Disease	MESH:D003920
26420861	475	486	cathepsin D	Gene	1509
26420861	515	521	leptin	Gene	3952
26420861	523	528	renin	Gene	5972
26420861	530	563	interleukin-1 receptor antagonist	Gene	3557
26420861	565	571	IL-1ra	Gene	3557
26420861	574	598	hepatocyte growth factor	Gene	3082
26420861	600	628	fatty acid-binding protein 4	Gene	2167
26420861	634	662	tissue plasminogen activator	Gene	5327
26420861	664	668	t-PA	Gene	5327
26420861	674	676	IR	Disease	MESH:D007333
26420861	760	762	IR	Disease	MESH:D007333
26420861	766	770	t-PA	Gene	5327
26420861	803	809	IL-1ra	Gene	3557
26420861	857	861	t-PA	Gene	5327
26420861	913	916	T2D	Disease	MESH:D003924
26420861	922	926	t-PA	Gene	5327
26420861	958	971	hyperglycemia	Disease	MESH:D006943
26420861	1043	1050	glucose	Chemical	MESH:D005947
26420861	1128	1133	renin	Gene	5972
26420861	1138	1141	T2D	Disease	MESH:D003924
26420861	1214	1220	IL-1ra	Gene	3557
26420861	1222	1226	t-PA	Gene	5327
26420861	1263	1266	T2D	Disease	MESH:D003924
26420861	1380	1383	T2D	Disease	MESH:D003924
26420861	1447	1458	cathepsin D	Gene	1509
26420861	1468	1470	IR	Disease	MESH:D007333
26420861	1514	1516	IR	Disease	MESH:D007333
26420861	1520	1524	t-PA	Gene	5327
26420861	Association	MESH:D007333	2167
26420861	Association	MESH:D007333	5972
26420861	Association	MESH:D007333	1509
26420861	Association	MESH:D007333	3082
26420861	Association	MESH:D003924	5972
26420861	Association	MESH:D003924	5327
26420861	Association	MESH:D007333	3952
26420861	Association	MESH:D006943	5327
26420861	Association	MESH:D003924	3557
26420861	Association	MESH:D007333	5327
26420861	Association	MESH:D007333	3557

